NEWT vs OIM

NewtekOne presents a classic 'value trap' profile, characterized by a very weak Piotroski F-Score of 2/9 indicating deteriorating fundamental health. While the stock is significantly undervalued relative to its Graham Number ($24.45) and Intrinsic Value ($15.26), this is offset by negative earnings growth (-6.00% YoY) and a high Debt/Equity ratio of 2.07. The strong dividend yield of 6.05% provides a floor, but the lack of growth and poor health metrics prevent a bullish rating. The discrepancy between the deep value metrics and the bearish technical trend suggests the market is pricing in fundamental risks.

OIM exhibits critical financial weakness with a Piotroski F-Score of 2/9, placing it firmly in the 'Weak' health category. As a shell company, it lacks operational revenue, profitability, and traditional valuation benchmarks, rendering the Graham Number and Intrinsic Value calculations inapplicable. The extreme negative Price/Book ratio (-3330.00) and a bearish technical trend (10/100) suggest significant underlying instability or accounting anomalies. The asset currently functions as a speculative vehicle with no fundamental growth drivers.